Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cabaletta Bio, Inc. (CABA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,420,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Co.'s proprietary technology utilizes Chimeric AutoAntibody Receptor, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Co.'s main CAAR T cell product candidate was designed based on the Chimeric Antigen Receptor, T cell technology that is marketed for the treatment of B cell cancers. Co.'s initial focus is mucosal pemphigus vulgaris, which is an autoimmune blistering disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 346,000
Total Buy Value $0 $0 $0 $343,789
Total People Bought 0 0 0 5
Total Buy Transactions 0 0 0 7
Total Shares Sold 0 33,000 110,000 110,000
Total Sell Value $0 $652,242 $1,694,746 $1,694,746
Total People Sold 0 1 1 1
Total Sell Transactions 0 3 9 9
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 40
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Binder Gwendolyn See Remarks   •       –      –    2024-01-19 4 AS $19.54 $215,439 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2024-01-19 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-12-19 4 AS $21.76 $240,789 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-12-19 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-11-20 4 AS $17.39 $196,014 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-11-20 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-10-19 4 AS $13.32 $146,921 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-10-19 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-09-19 4 AS $17.50 $193,220 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-09-19 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-08-21 4 AS $13.41 $147,583 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-08-21 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-07-19 4 AS $13.67 $152,022 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-07-19 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-06-20 4 AS $12.99 $142,925 D/D (11,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-06-20 4 OE $1.01 $11,110 D/D 11,000 31,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-05-19 4 AS $11.81 $259,833 D/D (22,000) 20,000     -
   Binder Gwendolyn See Remarks   •       –      –    2023-05-19 4 OE $1.01 $22,220 D/D 22,000 42,000     -
   Nichtberger Steven President & CEO   •       •      –    2022-10-19 4 B $1.25 $10,152 D/D 8,127 986,483 2.81     -
   Nichtberger Steven President & CEO   •       •      –    2022-10-18 4 B $0.99 $141,008 D/D 141,873 978,356 2.81     -
   Simon Mark Director   –       •      –    2022-10-18 4 B $0.98 $6,835 I/I 7,000 7,000 2.1     -
   Simon Mark Director   –       •      –    2022-10-18 4 B $0.98 $115,286 D/D 118,000 136,144 2.39     -
   Marda Anup Chief Financial Officer   •       –      –    2022-10-18 4 B $0.99 $49,620 D/D 50,000 50,000 2.74     -
   Binder Gwendolyn See Remarks   •       –      –    2022-10-18 4 B $0.99 $19,894 D/D 20,000 20,000 2.74     -
   Bollard Catherine Director   –       •      –    2022-10-18 4 B $0.99 $994 D/D 1,000 1,000 2.31     -
  40 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us